Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EPIQ Capital Group

Investor type Family Investment Office
Founders Chad Boeding

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$162M
Portfolio companies 11
Rounds per year 3.75
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 3
Key employees 4

Areas of investment

  • Biotechnology
  • Software
  • Therapeutics
  • Hardware
  • Robotics
Summary

EPIQ Capital Group is the famous VC, which was founded in 2018. The company was established in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

This organization was formed by Chad Boeding. We also calculated 4 valuable employees in our database.

Among the most popular portfolio startups of the fund, we may highlight Tenstorrent, Cortexyme. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The usual cause for the fund is to invest in rounds with 6 partakers. Despite the EPIQ Capital Group, startups are often financed by Dolby Family Ventures, Takeda Ventures, Pfizer. The meaningful sponsors for the fund in investment in the same round are Vulcan Capital, Verily, Takeda Ventures.

The high activity for fund was in 2019. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EPIQ Capital Group:
Typical Co-investors
EPIQ Capital Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EPIQ Capital Group:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AG Ventures Brooklyn, New York, United States
Axia8 Ventures China, Shanghai, Shanghai
Beijing Dabeinong Technology Group Beijing, China, Haidian
Bharat Petroleum Corp. Ballard Estate, India, Maharashtra
Chartwell Capital Florida, Palm City, United States
Denny Hill Capital Seattle, United States, Washington
Edovate Capital Colorado, Denver, United States
Grupo Sanborns Distrito Federal, Mexico, Mexico City
HENNGE Japan, Tokyo
Huaqing Bencao Investment Management China, Jiangsu, Nantong
Money Partners Group Japan, Tokyo
New Forge Germany, North Rhine-Westphalia, Solingen
Rimon Funds Herzliya, Israel, Tel Aviv
Sercel Carquefou, France, Pays de la Loire
Shanghai Yuhui Investment Management Co. China, Shanghai, Shanghai
Silicon Valley Community Foundation California, Mountain View, United States
Sunkem -
Unexo Bretagne, France, Rennes
Vattenfall AB Solna, Stockholms Lan, Sweden
Virgo Capital Austin, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Swift Navigation

Autonomous Vehicles
Drones
GPS
Hardware
Robotics
Software
$100M18 Oct 2022 San Francisco, California, United States

Spotlight Therapeutics

Biotechnology
Life Science
Therapeutics
$36M22 Mar 2022 Hayward, California, United States

SalioGen Therapeutics

Biotechnology
Life Science
Therapeutics
$115M05 Jan 2022 Burlington, Massachusetts, United States

VideoAmp

Advertising
Advertising Platforms
Business Intelligence
Digital Media
$275M21 Oct 2021 Los Angeles, California, United States

Windfall

Analytics
Computer
Financial Services
Software
$21M31 Mar 2021 San Francisco, California, United States

Swift Navigation

Autonomous Vehicles
Drones
GPS
Hardware
Robotics
Software
$50M09 Feb 2021 San Francisco, California, United States

Lucira Health

Biotechnology
Health Care
Health Diagnostics
$15M01 Dec 2020 California, United States

Food Delivery
Food Processing
Logistics
Supply Chain Management
Warehousing
$1B16 Sep 2020 Michigan, United States

Lucira Health

Biotechnology
Health Care
Health Diagnostics
07 Aug 2020 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EPIQ Capital Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: